Lasa Supergenerics Ltd - 540702 - Reg. 34 (1) Annual Report.
Please take note that the Eighth (8th) Annual General Meeting ("AGM") of the Members of the Company is scheduled to be held on Wednesday, September 27, 2023 at 12:30 PM via Video Conferencing (''VC'') facility or Other Audio Visual Means (''OAVM'') in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI). Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. September 02, 2023
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosures Requirement) Regulation 2015 we would like to inform you that the Board of Director at there Meeting Held Toady which commenced at 01.00 PM and Concluded at 4.45 P.M have Considering and Approved the Following: The Notice of the Eight (8th) Annual General Meeting (AGM)of the Company Director Report , CG, MDA and other relevant annexure and schedules thereof for the Financial Year Ended March 31 st March 2023. And Discuss any other Matters . Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 1.00 p.m. and concluded at 6.30 p.m. inter- alia have considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the quarter ended on June 30, 2023 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2023 3. The appointment of M/s. Gupta Rustagi & Co Chartered Accountant is subject to the approval of the Shareholders of the Company at the ensuing AGM. M/s Thanawala & Co., Chartered Accountants (FRN: 110948W), the present Statutory Auditors of the Company will complete their term at the conclusion of the ensuing 8th AGM of the Company. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2023
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Director of the Company is scheduled to be held on Monday , August 14, 2023 , inter alia; To consider, approve and take on records unaudited financial results of the Company for the quarter ended June 30, 2023. To discuss any other matter with the permission of the Chairperson Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
corporate office of the Company where books of accounts shall be maintained is shifted to Plot No. C-4, C-4/1, MIDC Lote parshuram Industrial area, Tal-Khed, Ratnagiri MH 415722 IN. Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations 2018, for the quarter ended June 30, 2023 , received from Bigshare Services Private Limited Registrars and Share Transfers Agents of the Company. Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
As per Company''s Code of Conduct for Regulating and Monitoring and Reporting of trading by insiders in terms of (Prohibition of Insiders Trading ), Regulation, 2015, as amended the trading window for dealing in the equity shares of the company has been closed for designated employees and their immediate relative w.e.f July 01, 2023, till 48 hours after the declaration of unaudited financial result (both inclusive days), for the quarter ended June 30, 2023. Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 please find enclosed herewith Disclosure of Related Party Transactions for the year ended March 31, 2023
